3D Ultrasound Imaging for Breast Cancer Diagnosis


About this study

The purpose of this study is to evaluate the effectiveess of a new 3D ultrasound imaging technology combining B-mode, microvessel imaging, shear wave elastography, and machine learning for breast lesion diagnosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult women, ≥ 18 years of age.
  • Breast lesion and are scheduled for clinically-indicated biopsy.

Exclusion Criteria:

  • < 18 years of age.
  • Previous breast surgery or breast implant.
  • Lacking capacity to consent.
  • Pregnant or lactating.
  • Receiving cancer therapy such as chemotherapy or radiation therapy.



Female patients with breast lesions scheduled for clinically indicated biopsy; age of 18 or above.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Open for enrollment

Contact information:

Bobbie Ott


More information


Publications are currently not available

Mayo Clinic Footer